Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl-Reference-Cited by-同舟云学术

Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl

Published:2014-12 Issue:12 Volume:20 Page:953-958
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Chin Melanie P.,Wrolstad Danielle,Bakris George L.,Chertow Glenn M.,de Zeeuw Dick,Goldsberry Angie,Linde Peter G.,McCullough Peter A.,McMurray John J.^ORCID,Wittes Janet,Meyer Colin J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1;Wu;Am J Physiol Renal Physiol,2011

2. KEAP1 E3 ligase–mediated downregulation of NF-kappaB signaling by targeting IKKbeta;Lee;Mol Cell,2009

3. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress;Dinkova-Kostova;Proc Natl Acad Sci U S A,2005

4. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults;Osburn;Mutat Res,2008

5. Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity;Chin;Am J Physiol Ren Physiol,2013

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pentacyclic triterpenes, potential novel therapeutic approaches for cardiovascular diseases;Archives of Pharmacal Research;2024-07-24

2. Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy;Frontiers in Pharmacology;2024-06-14

3. Lessons learned from early-stage clinical trials for diabetic nephropathy;Expert Opinion on Investigational Drugs;2024-03-15

4. Simvastatin-Mediated Nrf2 Activation Induces Fetal Hemoglobin and Antioxidant Enzyme Expression to Ameliorate the Phenotype of Sickle Cell Disease;Antioxidants;2024-03-11

5. Bardoxolone methyl attenuates doxorubicin‐induced cardiotoxicity by inhibiting the TXNIP–NLRP3 pathway through Nrf2 activation;Environmental Toxicology;2023-12-08